Skip to main content
. 2022 Jun 21;13(4):367–378. doi: 10.6004/jadpro.2022.13.4.2

Table 2. General Patient History Between Solid and Hematologic Malignancies.

History, n (%) ST (n = 143) HM (n = 62) Total (n = 205)
Health-care history
Recent admission within the past 30 days, n (%) 35 (24.5) 18 (29) 53 (25.8)
Procedure in past 30 days (non-cancer related), n (%) 41 (28.7) 0 (0) 41 (20.0)
Average no. of admissions in the past year 2 ± 1.7 1.8 ± 2.2 1.6 ± 1.9
Average no. of ED visits in the past year 1.9 ± 2.2 1.3 ± 1.6 1.7 ± 2.0
Recent oncologic history
Cancer-related procedure in past 30 days, n (%) 25 (17.5) 2 (3.2) 27 (13)
Recent clinic visit within the past 30 days, n (%) 104 (72.7) 48 (77.4) 152 (74.1)
Chemotherapy in past 30 days, n (%) 104 (72.7) 39 (62.9) 143 (69.8)
Radiation in past 30 days, n (%) 15 (10.5) 0 (0) 15 (7.3)
Status post SCT, n (%) 0 (0) 3 (4.8) 3 (1.5)
Treatment characteristics
Oral chemotherapy, n (%) 29 (20.2) 15 (24.2) 44 (21.5)
IV chemotherapy, n (%) 69 (48.2) 32 (51.6) 102 (49.8)
Combination IV/po chemotherapy, n (%) 2 (1.4) 6 (9.6) 7 (3.4)
Nonchemotherapy cancer drug, n (%) 14 (11.2) 0 (0) 14 (6.8)
Not on treatment (new diagnosis/on-hold), n (%) 27 (18.9) 3 (4.8) 30 (14.6)

Note. ST = solid tumor; HM = hematologic malignancy; ED = emergency department; SCT = stem cell transplant.